Semaglutide is administered as a convenient, once-weekly injection, which many of our patients at Centra Internal Medicine find preferable to daily oral medications
GLP-1 + GIP (tirzepatide class): around 16% average weight loss over 12 to 18 months, per Cochrane Collaboration and randomized-controlled-trial data the brand cites
Small lapses by untrained or rushed team members leaving vials open, mishandling packaging, or returning samples to the wrong temperature can accumulate into significant problems over time
GLP-1 medications like Semaglutide and Tirzepatide are clinically proven to help patients achieve significant, sustainable weight loss
What monitoring is recommended for patients taking oral semaglutide in a primary care or internal medicine setting
^ If I did this again, I'd start at a lower dose to minimize the side effects